MENU
MGX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Metagenomi Therapeutics (MGX) Ownership - Who owns Metagenomi Therapeutics?

Metagenomi Therapeutics Inc is an vivo genome editing company capitalizing on its proprietary technologies to create curative genetic medicines for patients... Show more

Profile

Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
119
Web
https://metagenomi.co

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
44.8M
P/E Ratio
N/A
Total Cash
140.16M
Projected Growth
N/A
Total Debt
39.19M
Revenue
22.33M
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
3.72
Total Debt/Equity
N/A
Revenue/Share
0.60 USD as % of share price
View a ticker or compare two or three
MGX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details
Industry
N/A
Address
5959 Horton Street
Phone
+1 510 871-4880
Employees
119
Web
https://metagenomi.co